Aphria, Cannabis in the News, Canopy Growth, CBD Stocks, Cronos Group, Gw Pharmaceuticals, Hemp, Investment Opportunities, marijuana stock, Organigram, Tilray
Global Cannabis Beverages Market to Reach $2 Billion by 2026 — SAN FRANCISCO, Sept. 10, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report...
Cannabis in the News, Cresco, Curaleaf, marijuana stock, Organigram, Research, Safety, Stock Talk, Technology/Innovations
Developers Strive to Create Innovative Safeguards Against Cannabis Abuse — NEW YORK, July 6, 2021 /PRNewswire/ — The cannabis market continues to prove that there is a high demand for such products across the world. The expanding nature of cannabis...
Cannabis in the News, Investment Opportunities, marijuana stock, Organigram, Stock Talk
Organigram is one of Canada’s leading licensed producers of high-quality recreational and medical cannabis. The company was founded in 2013 as a medical cannabis provider. Now, it is working towards developing an international business partnership to be able to...
Cannabis in the News, Investment Opportunities, marijuana stock, Organigram, Stock Talk
Should You Avoid Organigram Stock in 2021? The global cannabis market has been growing rapidly over the last few years making it one of the most preferred industries for investors. The Canada-based company Organigram Holdings (NASDAQ: OGI) is a popular licensed...
Cannabis in the News, Financial Results, marijuana stock, Organigram, Stock Talk
Organigram (OGI) Reports Q4 2020 Results Organigram (OGI) just reported its Q4 2020 results and here are the key highlights from the earnings call: Q4 2020 net revenue increased 25% to $20.4 million from $16.3 million in Q4 2019 Q4 2020 gross revenue increased 32% to...